Target

Covid-19: Vaccination plus infection offers best protection, finds study led by WHO
“Hybrid immunity” derived from a mix of infection by SARS-CoV-2 and vaccination provides higher prot...

Influenza virus characterization - Summary Europe, December 2022
The November 2022 characterization report, was the second report for the 2022-2023 influenza season....

Outbreak and Crisis Response Appeal 2023
Serving the most vulnerable during crisis In 2023, WHO needs US$ 2.54bn to continue to fund cost-ef...

Joint FAO/WHO Expert Meeting on the pre- and post-harvest control of Campylobacter spp. in poultry meat
Salmonellosis and campylobacteriosis are among the most frequently reported foodborne diseases world...

Practical manual on tuberculosis laboratory strengthening, 2022 update
The Practical manual on laboratory strengthening, 2022 update provides practical guidance ...

Pilot decision workshop to aid prioritization of resources for malaria control in Ghana
Overview This report provides a summary of the discussions held during a 2-day workshop organized b...

How Do I Screen for HIV? | Screening | Clinicians | HIV | CDC
Taking HIV treatment prevents sexual transmission of HIV Three landmark studies have shown that tre...

Early and Increased Influenza Activity Among Children ...
What is already known about this topic? During fall 2022, many states reported increased respirator...

Reasons for Receiving or Not Receiving Bivalent COVID ...
What is already known about this topic? Bivalent COVID-19 booster vaccines increase protection agai...

Epidemiology of Human Mpox ...
What is already known about this topic? The number of mpox cases reported from rural areas in West ...

WHO Webinar Series on Trust and Pandemic Preparedness: Webinar 1: Trust and pandemics
The COVID-19 pandemic highlighted trust as an important determinant of successful pandemic response&...

Multi-country outbreak of mpox, External situation report#14- 19 January 2023
This is the 14th situation report for the multi-country outbreak of mpox, which provides details on ...

Covid-19: What do we know about XBB.1.5 and should we be worried?
What is XBB.1.5? XBB.1.5 is yet another omicron subvariant, and follows on from XBB and XBB.1. Scie...

WHO Policy Brief: Gatherings in the context of COVID-19, 19 January 2023
Gatherings are events characterized by the concentration of people at a specific location for a spec...

Public health management of possible cases - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Individuals who are a possible COVID-19 case should follow the actions here. NHS inform gives ...

Operational manual on leishmaniasis vector control, surveillance, monitoring and evaluation
Despite the significant role of vector control in national leishmaniasis control programmes, the pro...

COVID-19 Symptoms 6 Months After Onset and the Role of Vaccination for SARS-CoV-2 Infection
Key Points Question  What factors are associated with persistent post–COVID-19 symptoms, ...

Human infection caused by avian influenza A(H5) - Ecuador
On 9 January 2023, WHO was notified of a human infection caused by an avian influenza A(H5) virus. T...

Experimental HIV vaccine regimen safe but ineffective, study finds
An investigational HIV vaccine regimen tested among men who have sex with men (MSM) and transgender ...

8th WHO Technical Taskforce: Defeating Meningitis by 2030 – A Global Road Map
The 8th meeting was held from Tuesday 13th – Thursday 15th December 2022, chaired by Profe...



Profilo